https://www.mdpi.com/1999-4923/15/2/547?fbclid=IwAR1e5tCd6jP1jqJ8jVkzLjzYOaB23RUMQ4TNMnPO8TZ_wx-IH3MgKzdRbeM
Bioavailability of weakly basic drugs may be disrupted by dramatic pH changes or unexpected pH alterations in the gastrointestinal tract. Conventional organic...
designoptimizationnanoparticulateporeformer
https://pubmed.ncbi.nlm.nih.gov/3735097/
Two lubricants, magnesium stearate and sodium stearyl fumarate, were compared under identical mixing conditions to study their roles in drug-excipient...
drugexcipientinteractionsresultingpowder
https://www.businesswire.com/news/home/20250324122216/en/IFF-Pharma-Solutions-Brings-Next-Gen-Excipient-Innovations-to-CPHI-Japan-2025
IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its in...
pharma solutionsnext geniffbringsexcipient
https://www.emergenresearch.com/industry-report/nutraceutical-excipient-market
The Nutraceutical Excipient Market size is expected to reach a valuation of USD 9036.5 million in 2033 growing at a CAGR of 8.0%. The research report...
market sizetrend analysisnutraceuticalexcipientshare
https://www.mja.com.au/journal/2015/203/5/warfarin-or-excipient-allergy-clinical-dilemma-resolved
Excipient allergy should be considered in patients with a reaction to warfarin
warfarinexcipientallergyclinicaldilemma